TCM Daoyin Therapy in Individuals At-risk for COPD
TCM Daoyin Therapy in Early Chronic Obstructive Pulmonary Disease: A Pilot Study
1 other identifier
interventional
60
1 country
2
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease. The aim of prospective randomized study is to evaluate the effects of TCM Daoyin training on Individuals at-risk for COPD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease
Started Jan 2023
Longer than P75 for not_applicable chronic-obstructive-pulmonary-disease
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2023
CompletedFirst Submitted
Initial submission to the registry
July 4, 2023
CompletedFirst Posted
Study publicly available on registry
July 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
April 3, 2025
March 1, 2025
4.5 years
July 4, 2023
March 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Lung function
Participants' lung function (FVC、FVC%、FEV1、FEV1%、FEV1/FVC) will be tested to identify air flow condition in both group.
Change from Baseline lung function at 16 weeks
Secondary Outcomes (6)
6-min walk distance(6MWD)
Change from Baseline 6MWD at 16 weeks
Immune function
Change from Baseline immune function at 16 weeks
Depression, Anxiety and Stress Scale-21 item (DASS-21)
Change from Baseline DASS-21 at 16 weeks
St. George's Respiratory Questionnaire (SGRQ)
Change from Baseline SGRQ at 16 weeks
Adverse effects
8 weeks
- +1 more secondary outcomes
Study Arms (2)
TCM Daoyin intervention group
EXPERIMENTALParticipants randomized to TCM Daoyin intervention group receive health education plus a TCM Daoyin training program. The TCM Daoyin training program was a 16-week, instructor-led group training program.
Health education control group
ACTIVE COMPARATORParticipants randomized to the health education control group only receive health education and no additional training program.
Interventions
The TCM Daoyin training program consisted of two 90-min training classes and at least five 30-min at-home practice sessions per week for 16-weeks. All sessions included 10 min of warmup and 10 min of cooldown.
Health education is provided by doctor and nurse, including work, rest, diet and other basic programs.
Eligibility Criteria
You may qualify if:
- Subject at-risk for COPD (Chronic obstructive pulmonary disease screening questionnaire (COPD-SQ) score≥16; and pre-bronchodilator FEV1/FVC ≥ 0.70, or pre-bronchodilator FEV1/FVC\<0.70 but post-bronchodilator FEV1/FVC ≥ 0.70).
- Aged 40 to 75, male or female.
- Subject has a clear mind and the ability to lead an independent life.
- Subject agrees to perform a blood-test.
- Subject agrees to participate in this study and sign to the informed consent.
You may not qualify if:
- Subject with acute exacerbation of COPD.
- Subject with respiratory infectious disease (e.g., tuberculosis, influenza, etc.) within 1 month.
- Subject with serious current unstable physical illness and mental illness.
- Subject with definite clinical diagnosis of Alzheimer's disease, or severe cognitive impairment.
- Subject is pregnant or lactating women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Shanghai Qigong Research Institute
Shanghai, Shanghai Municipality, 021, China
Changzheng Community Health Service Center of Putuo District, Shanghai
Shanghai, Shanghai Municipality, 200333, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xiaoting Zhao
Shanghai Qigong Research Institute
- STUDY DIRECTOR
Jie Li, Doctor
Shanghai University of Traditional Chinese Medicine
- PRINCIPAL INVESTIGATOR
Ying Lu, Master
Shanghai Qigong Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The outcome assessors were blinded to the group allocation of the participants.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant researcher
Study Record Dates
First Submitted
July 4, 2023
First Posted
July 11, 2023
Study Start
January 3, 2023
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
April 3, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share